Metagenomi Therapeutics, Inc. Lease, Cost
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-03-05
- Metagenomi Therapeutics, Inc. lease, cost for fiscal 2025 was $13.37M, a 3.19% increase from fiscal 2024.
- Metagenomi Therapeutics, Inc. lease, cost for fiscal 2024 was $12.96M, a 4.38% increase from fiscal 2023.
- Metagenomi Therapeutics, Inc. lease, cost for fiscal 2023 was $12.42M.
| Period end | Lease, Cost 12 month |
|---|---|
| 2025-12-31 | $13.37M 10-K · filed 2026-03-05 |
| 2024-12-31 | $12.96M 10-K · filed 2026-03-05 |
| 2023-12-31 | $12.42M 10-K · filed 2025-03-17 |